Template:ID-Parasitic meningitis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
mNo edit summary
No edit summary
 
(14 intermediate revisions by 2 users not shown)
Line 1: Line 1:
* Protozoal meningitis
* Meningitis, parasitic
:* Pathogen-directed antimicrobial therapy
:*1. '''Protozoal meningitis'''
::* '''Naegleria fowleri (primary amebic meningoencephalitis)'''<ref>{{Cite journal| doi = 10.1542/peds.2014-2292| issn = 1098-4275| volume = 135| issue = 3| pages = –744-748| last1 = Linam| first1 = W. Matthew| last2 = Ahmed| first2 = Mubbasheer| last3 = Cope| first3 = Jennifer R.| last4 = Chu| first4 = Craig| last5 = Visvesvara| first5 = Govinda S.| last6 = da Silva| first6 = Alexandre J.| last7 = Qvarnstrom| first7 = Yvonne| last8 = Green| first8 = Jerril| title = Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis| journal = Pediatrics| date = 2015-03| pmid = 25667249}}</ref><ref>{{Cite journal| issn = 0188-4409| volume = 36| issue = 1| pages = 83–86| last1 = Vargas-Zepeda| first1 = Jesús| last2 = Gómez-Alcalá| first2 = Alejandro V.| last3 = Vásquez-Morales| first3 = José Alfonso| last4 = Licea-Amaya| first4 = Leonardo| last5 = De Jonckheere| first5 = Johan F.| last6 = Lares-Villa| first6 = Fernando| title = Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin| journal = Archives of Medical Research| date = 2005-02| pmid = 15900627}}</ref>
::*1.1 '''Naegleria fowleri (primary amebic meningoencephalitis)'''<ref>{{Cite journal| doi = 10.1542/peds.2014-2292| issn = 1098-4275| volume = 135| issue = 3| pages = –744-748| last1 = Linam| first1 = W. Matthew| last2 = Ahmed| first2 = Mubbasheer| last3 = Cope| first3 = Jennifer R.| last4 = Chu| first4 = Craig| last5 = Visvesvara| first5 = Govinda S.| last6 = da Silva| first6 = Alexandre J.| last7 = Qvarnstrom| first7 = Yvonne| last8 = Green| first8 = Jerril| title = Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis| journal = Pediatrics| date = 2015-03| pmid = 25667249}}</ref><ref>{{Cite journal| issn = 0188-4409| volume = 36| issue = 1| pages = 83–86| last1 = Vargas-Zepeda| first1 = Jesús| last2 = Gómez-Alcalá| first2 = Alejandro V.| last3 = Vásquez-Morales| first3 = José Alfonso| last4 = Licea-Amaya| first4 = Leonardo| last5 = De Jonckheere| first5 = Johan F.| last6 = Lares-Villa| first6 = Fernando| title = Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin| journal = Archives of Medical Research| date = 2005-02| pmid = 15900627}}</ref>
:::* Preferred regimen: [[Amphotericin B]] 1.5 mg/kg/day IV q12h for 3 days, followed by [[Amphotericin B]] 1 mg/kg/day IV for 6 days {{and}} [[Amphotericin B]] 1.5 mg/kg/day intrathecal for 2 days, followed by [[Amphotericin B]] 1 mg/kg/day intrathecal qod for 8 days
:::* Preferred regimen: ([[Amphotericin B]] 1.5 mg/kg/day IV q12h for 3 days, followed by [[Amphotericin B]] 1 mg/kg/day IV q24h for 11 days) {{and}} ([[Amphotericin B]] 1.5 mg/kg/day intrathecal q24h for 2 days, followed by [[Amphotericin B]] 1 mg/kg/day intrathecal qod for 8 days) {{and}} [[Azithromycin]] 10 mg/kg/day IV/PO q24h for 28 days {{and}} [[Fluconazole]] 10 mg/kg/day IV/PO q24h for 28 days {{and}} [[Rifampin]] 10 mg/kg/day IV/PO q24h for 28 days {{and}} [[Miltefosine]] 50 mg PO bid–tid for 28 days {{and}} [[Dexamethasone]] 0.15 mg/kg IV q6h for 4 days
:::* Alternative regimen: [[Amphotericin B]] 0.25–1 mg/kg/day IV q24h for 2 weeks {{and}} [[Fluconazole]] 10 mg/kg IV q24h for 30 days {{and}} [[Rifampicin]] 10 mg/kg PO qd for 30 days {{and}} [[Dexamethasone]] 0.15 mg/kg IV q6h for 30 days
 
::*1.2 '''Toxoplasma gondii'''<ref>{{cite book | last = Bennett | first = John | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Elsevier/Saunders | location = Philadelphia, PA | year = 2015 | isbn = 978-1455748013 }}</ref>
:::* Preferred regimen: [[Sulfadiazine]] 4–6 g/day q6h {{and}} [[Pyrimethamine]] 25–100 mg/day qd
:::* Alternative regimen (1): [[Pyrimethamine]] 25–100 mg/day qd {{and}} [[Clindamycin]] 2400–4800 mg/day IV q6h
:::* Alternative regimen (2): [[Pyrimethamine]] 25–100 mg/day qd {{and}} ([[Azithromycin]] 1200–1500 mg/day IV q24h {{or}} [[Atovaquone]] 750 mg IV q6h {{or}} [[Dapsone]] 100 mg PO q24h)
:::* Alternative regimen (3): [[TMP-SMZ]] 10–20 mg/kg/day q6–12h
 
:*2. '''Helminthic meningitis'''
::*2.1 '''Angiostrongylus cantonensis'''<ref>{{Cite journal| doi = 10.1016/S1473-3099(08)70229-9| issn = 1473-3099| volume = 8| issue = 10| pages = 621–630| last1 = Wang| first1 = Qiao-Ping| last2 = Lai| first2 = De-Hua| last3 = Zhu| first3 = Xing-Quan| last4 = Chen| first4 = Xiao-Guang| last5 = Lun| first5 = Zhao-Rong| title = Human angiostrongyliasis| journal = The Lancet. Infectious Diseases| date = 2008-10| pmid = 18922484}}</ref><ref>{{Cite journal| doi = 10.1086/595852| issn = 1537-6591| volume = 48| issue = 3| pages = 322–327| last1 = Ramirez-Avila| first1 = Lynn| last2 = Slome| first2 = Sally| last3 = Schuster| first3 = Frederick L.| last4 = Gavali| first4 = Shilpa| last5 = Schantz| first5 = Peter M.| last6 = Sejvar| first6 = James| last7 = Glaser| first7 = Carol A.| title = Eosinophilic meningitis due to Angiostrongylus and Gnathostoma species| journal = Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America| date = 2009-02-01| pmid = 19123863}}</ref>
:::* Preferred regimen: [[Albendazole]] 15–20 mg/kg/day PO qd–bid for 10–20 days {{and}} [[Dexamethasone]] 10–20 mg PO qd for 10–20 days
:::* Alternative regimen: [[Mebendazole]] 100 mg PO bid for 10–20 days {{and}} [[Dexamethasone]] 10–20 mg PO qd for 10–20 days
 
::*2.2 '''Baylisascaris procyonis'''<ref>{{Cite journal| doi = 10.1128/CMR.18.4.703-718.2005| issn = 0893-8512| volume = 18| issue = 4| pages = 703–718| last1 = Gavin| first1 = Patrick J.| last2 = Kazacos| first2 = Kevin R.| last3 = Shulman| first3 = Stanford T.| title = Baylisascariasis| journal = Clinical Microbiology Reviews| date = 2005-10| pmid = 16223954| pmc = PMC1265913}}</ref><ref>{{Cite journal| doi = 10.1086/425364| issn = 1537-6591| volume = 39| issue = 10| pages = 1484–1492| last1 = Murray| first1 = William J.| last2 = Kazacos| first2 = Kevin R.| title = Raccoon roundworm encephalitis| journal = Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America| date = 2004-11-15| pmid = 15546085}}</ref>
:::* Preferred regimen: [[Albendazole]] 25–50 mg/kg PO qd or 400 mg PO bid for 10 days {{and}} [[Dexamethasone]] 10–20 mg PO qd for 10 days
:::* Alternative regimen: [[Thiabendazole]] 50 mg/kg/day PO bid for 10 days {{and}} [[Dexamethasone]] 10–20 mg PO qd for 10 days
 
::*2.3 '''Gnathostoma spinigerum'''<ref>{{Cite journal| doi = 10.1128/CMR.00003-09| issn = 1098-6618| volume = 22| issue = 3| pages = 484–492| last1 = Herman| first1 = Joanna S.| last2 = Chiodini| first2 = Peter L.| title = Gnathostomiasis, another emerging imported disease| journal = Clinical Microbiology Reviews| date = 2009-07| pmid = 19597010| pmc = PMC2708391}}</ref><ref>{{Cite journal| doi = 10.1086/595852| issn = 1537-6591| volume = 48| issue = 3| pages = 322–327| last1 = Ramirez-Avila| first1 = Lynn| last2 = Slome| first2 = Sally| last3 = Schuster| first3 = Frederick L.| last4 = Gavali| first4 = Shilpa| last5 = Schantz| first5 = Peter M.| last6 = Sejvar| first6 = James| last7 = Glaser| first7 = Carol A.| title = Eosinophilic meningitis due to Angiostrongylus and Gnathostoma species| journal = Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America| date = 2009-02-01| pmid = 19123863}}</ref>
:::* Preferred regimen: [[Albendazole]] 400 mg PO bid for 3 weeks {{and}} [[Dexamethasone]] 10–20 mg PO qd for 3 weeks
:::* Alternative regimen: [[Ivermectin]] 0.2 mg/kg PO qd for 2 days {{and}} [[Dexamethasone]] 10–20 mg PO qd for 3 weeks
 
 
==References==
{{reflist|2}}

Latest revision as of 20:17, 11 August 2015

  • Meningitis, parasitic
  • 1. Protozoal meningitis
  • 1.1 Naegleria fowleri (primary amebic meningoencephalitis)[1][2]
  • 1.2 Toxoplasma gondii[3]
  • 2. Helminthic meningitis
  • 2.1 Angiostrongylus cantonensis[4][5]
  • Preferred regimen: Albendazole 15–20 mg/kg/day PO qd–bid for 10–20 days AND Dexamethasone 10–20 mg PO qd for 10–20 days
  • Alternative regimen: Mebendazole 100 mg PO bid for 10–20 days AND Dexamethasone 10–20 mg PO qd for 10–20 days
  • 2.2 Baylisascaris procyonis[6][7]
  • 2.3 Gnathostoma spinigerum[8][9]


References

  1. ↑ Linam, W. Matthew; Ahmed, Mubbasheer; Cope, Jennifer R.; Chu, Craig; Visvesvara, Govinda S.; da Silva, Alexandre J.; Qvarnstrom, Yvonne; Green, Jerril (2015-03). "Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis". Pediatrics. 135 (3): –744-748. doi:10.1542/peds.2014-2292. ISSN 1098-4275. PMID 25667249. Check date values in: |date= (help)
  2. ↑ Vargas-Zepeda, Jesús; Gómez-Alcalá, Alejandro V.; Vásquez-Morales, José Alfonso; Licea-Amaya, Leonardo; De Jonckheere, Johan F.; Lares-Villa, Fernando (2005-02). "Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin". Archives of Medical Research. 36 (1): 83–86. ISSN 0188-4409. PMID 15900627. Check date values in: |date= (help)
  3. ↑ Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455748013.
  4. ↑ Wang, Qiao-Ping; Lai, De-Hua; Zhu, Xing-Quan; Chen, Xiao-Guang; Lun, Zhao-Rong (2008-10). "Human angiostrongyliasis". The Lancet. Infectious Diseases. 8 (10): 621–630. doi:10.1016/S1473-3099(08)70229-9. ISSN 1473-3099. PMID 18922484. Check date values in: |date= (help)
  5. ↑ Ramirez-Avila, Lynn; Slome, Sally; Schuster, Frederick L.; Gavali, Shilpa; Schantz, Peter M.; Sejvar, James; Glaser, Carol A. (2009-02-01). "Eosinophilic meningitis due to Angiostrongylus and Gnathostoma species". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 48 (3): 322–327. doi:10.1086/595852. ISSN 1537-6591. PMID 19123863.
  6. ↑ Gavin, Patrick J.; Kazacos, Kevin R.; Shulman, Stanford T. (2005-10). "Baylisascariasis". Clinical Microbiology Reviews. 18 (4): 703–718. doi:10.1128/CMR.18.4.703-718.2005. ISSN 0893-8512. PMC 1265913. PMID 16223954. Check date values in: |date= (help)
  7. ↑ Murray, William J.; Kazacos, Kevin R. (2004-11-15). "Raccoon roundworm encephalitis". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 39 (10): 1484–1492. doi:10.1086/425364. ISSN 1537-6591. PMID 15546085.
  8. ↑ Herman, Joanna S.; Chiodini, Peter L. (2009-07). "Gnathostomiasis, another emerging imported disease". Clinical Microbiology Reviews. 22 (3): 484–492. doi:10.1128/CMR.00003-09. ISSN 1098-6618. PMC 2708391. PMID 19597010. Check date values in: |date= (help)
  9. ↑ Ramirez-Avila, Lynn; Slome, Sally; Schuster, Frederick L.; Gavali, Shilpa; Schantz, Peter M.; Sejvar, James; Glaser, Carol A. (2009-02-01). "Eosinophilic meningitis due to Angiostrongylus and Gnathostoma species". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 48 (3): 322–327. doi:10.1086/595852. ISSN 1537-6591. PMID 19123863.
Retrieved from "https://www.wikidoc.org/index.php?title=Template:ID-Parasitic_meningitis&oldid=1130401"